Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-04
DOI
10.1038/s41467-017-02119-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease
- (2016) Mónica Cristina García et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression
- (2016) Judith Fraussen et al. AUTOIMMUNITY REVIEWS
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination
- (2016) Michael B. Keough et al. Nature Communications
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
- (2015) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction
- (2014) Silvia Di Prisco et al. BRITISH JOURNAL OF PHARMACOLOGY
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- (2014) Lukas Haider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The central role of mitochondria in axonal degeneration in multiple sclerosis
- (2014) Graham R Campbell et al. Multiple Sclerosis Journal
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Iron and neurodegeneration in the multiple sclerosis brain
- (2013) Simon Hametner et al. ANNALS OF NEUROLOGY
- Screening for Inhibitors of Microglia to Reduce Neuroinflammation
- (2013) Shazia Samanani et al. CNS & Neurological Disorders-Drug Targets
- Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
- (2013) Edward Lauterbach INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL/6 mice: Brain region specific changes
- (2013) Masanori Ookubo et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
- (2013) David W Hampton et al. Acta Neuropathologica Communications
- Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination
- (2012) Lorraine W. Lau et al. ANNALS OF NEUROLOGY
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Desipramine Protects Neuronal Cell Death and Induces Heme Oxygenase-1 Expression in Mes23.5 Dopaminergic Neurons
- (2012) Hsiao-Yun Lin et al. PLoS One
- Imipramine enhances neuroprotective effect of PEP-1-Catalase against ischemic neuronal damage
- (2011) Dae-Won Kim et al. BMB Reports
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation
- (2011) Xiaoming Hu et al. Journal of Neuroimmune Pharmacology
- Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis
- (2011) Sarah Al-Izki et al. Multiple Sclerosis Journal
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
- (2010) Graham R. Campbell et al. ANNALS OF NEUROLOGY
- Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation
- (2009) Angelika Goncalves DaSilva et al. AMERICAN JOURNAL OF PATHOLOGY
- Different methods for control and comparison of the antioxidant properties of vegetables
- (2009) Milan Číž et al. FOOD CONTROL
- Quinpramine is a novel compound effective in ameliorating brain autoimmune disease
- (2008) Mahendra P. Singh et al. EXPERIMENTAL NEUROLOGY
- An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss
- (2008) David W. Hampton et al. JOURNAL OF NEUROIMMUNOLOGY
- Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
- (2008) Jaegyu Hwang et al. NEUROPHARMACOLOGY
- Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway
- (2007) Chi-Hsien Peng et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells
- (2003) Kazue Hisaoka et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started